Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Paricalcitol Patent Expiration

Paricalcitol is Used for managing secondary hyperparathyroidism in chronic kidney disease. It was first introduced by Abbvie Inc in its drug Zemplar on Apr 17, 1998. Another drug containing Paricalcitol is Paricalcitol. 16 different companies have introduced drugs containing Paricalcitol.


Paricalcitol Patents

Given below is the list of patents protecting Paricalcitol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zemplar US6136799

(Pediatric)

 Cosolvent formulations Oct 08, 2018

(Expired)

 Abbvie
Zemplar US6361758

(Pediatric)

 Cosolvent formulations Oct 08, 2018

(Expired)

 Abbvie
Zemplar US6136799 Cosolvent formulations Apr 08, 2018

(Expired)

 Abbvie
Zemplar US6361758 Cosolvent formulations Apr 08, 2018

(Expired)

 Abbvie
Zemplar US5597815

(Pediatric)

 Prevention of hyperphosphatemia in kidney disorder patients Jan 13, 2016

(Expired)

 Abbvie
Zemplar US5597815 Prevention of hyperphosphatemia in kidney disorder patients Jul 13, 2015

(Expired)

 Abbvie
Zemplar US5587497

(Pediatric)

 19-nor-vitamin D compounds Jun 24, 2014

(Expired)

 Abbvie
Zemplar US5587497 19-nor-vitamin D compounds Dec 24, 2013

(Expired)

 Abbvie
Zemplar US5246925

(Pediatric)

 19-nor-vitamin D compounds for use in treating hyperparathyroidism Oct 17, 2012

(Expired)

 Abbvie



Paricalcitol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Paricalcitol Generic API Manufacturers

Several generic applications have been filed for Paricalcitol. The first generic version for Paricalcitol was by Sandoz Inc and was approved on Jul 27, 2011. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Oct 9, 2018.

Given below is the list of companies who have filed for Paricalcitol generic, along with the locations of their manufacturing plants worldwide.


1. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MCG

capsule Prescription ORAL AB Jan 13, 2016
2MCG

capsule Prescription ORAL AB Jan 13, 2016
4MCG

capsule Prescription ORAL AB Jan 13, 2016





2. AMNEAL PHARMS CO

Amneal Pharmaceuticals Co Gmbh has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.002MG/ML (0.002MG/ML)

solution Prescription INTRAVENOUS AP Mar 9, 2017
0.005MG/ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Mar 9, 2017
0.01MG/2ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Mar 9, 2017





3. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MCG

capsule Prescription ORAL AB Jan 14, 2016
2MCG

capsule Prescription ORAL AB Jan 14, 2016
1MCG

capsule Prescription ORAL AB Jan 14, 2016


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





4. BIONPHARMA

Bionpharma Inc has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MCG

capsule Prescription ORAL AB Mar 27, 2014
1MCG

capsule Prescription ORAL AB Mar 27, 2014
2MCG

capsule Prescription ORAL AB Mar 27, 2014


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





5. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 6 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MCG

capsule Prescription ORAL AB Jun 24, 2014
1MCG

capsule Prescription ORAL AB Jun 24, 2014
4MCG

capsule Prescription ORAL AB Jun 24, 2014
0.002MG/ML (0.002MG/ML)

solution Prescription INTRAVENOUS AP Aug 17, 2016
0.005MG/ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Aug 17, 2016
0.01MG/2ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Aug 17, 2016





6. EPIC PHARMA LLC

Epic Pharma Llc has filed for 1 generic for Paricalcitol. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/2ML (0.005MG/ML)

solution Discontinued INTRAVENOUS N/A Oct 16, 2017





7. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005MG/ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Oct 9, 2018
0.002MG/ML (0.002MG/ML)

solution Prescription INTRAVENOUS AP Oct 9, 2018
0.01MG/2ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Oct 9, 2018


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited





8. LOTUS PHARM CO LTD

Lotus Pharmaceutical Co Ltd Nantou Plant has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Lotus Pharm Co Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MCG

capsule Discontinued ORAL N/A Feb 24, 2016
2MCG

capsule Discontinued ORAL N/A Feb 24, 2016
4MCG

capsule Discontinued ORAL N/A Feb 24, 2016





9. MARKSANS PHARMA

Marksans Pharma Ltd has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Marksans Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MCG

capsule Prescription ORAL AB Oct 7, 2016
2MCG

capsule Prescription ORAL AB Oct 7, 2016
1MCG

capsule Prescription ORAL AB Oct 7, 2016


Manufacturing Plant Locations
New

Marksans Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Marksans Pharma as present at those locations.

Country City Firm Name
United States
Commack Marksans Pharmaceuticals Ltd
India
Verna Marksans Pharma Limited





10. RISING

Rising Pharma Holdings Inc has filed for 6 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MCG

capsule Prescription ORAL AB Jun 24, 2014
2MCG

capsule Prescription ORAL AB Jun 24, 2014
4MCG

capsule Prescription ORAL AB Jun 24, 2014
0.002MG/ML (0.002MG/ML)

solution Discontinued INTRAVENOUS N/A Nov 2, 2017
0.005MG/ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Nov 2, 2017
0.01MG/2ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Nov 2, 2017


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Rising Sun Rising Sun Veterinary Clinic
Fort Bragg Rising Tide Sea Vegetables
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
Saddle Brook Rising Pharmaceuticals, Inc.
East Brunswick Rising Pharma Holding, Inc.
Livingston Risingsun Iodine Products Corp.
Phoenix Rising Sun Farms Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





11. SANDOZ

Sandoz Inc has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.002MG/ML (0.002MG/ML)

solution Prescription INTRAVENOUS AP Jul 27, 2011
0.01MG/2ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Jul 27, 2011
0.005MG/ML (0.005MG/ML)

solution Prescription INTRAVENOUS AP Jul 27, 2011


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





12. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Paricalcitol. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MCG

capsule Prescription ORAL AB Sep 27, 2013
1MCG

capsule Prescription ORAL AB Sep 27, 2013
4MCG

(reference standard)

capsule Prescription ORAL AB Sep 27, 2013